Anavex Life Sciences Corp.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AVXL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

162,124

Value ($000)

577

Weight

0.0%

2021 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	577	0.0%	162,124	12/31/2025
2025 Q3	11/14/2025	1,442	0.0%	162,053	9/30/2025
2025 Q2	8/14/2025	2,100	0.0%	227,741	6/30/2025
2025 Q1	5/19/2025	846	0.0%	98,634	3/31/2025
2024 Q1	5/15/2024	493	0.0%	96,924	3/31/2024
2023 Q4	2/14/2024	902	0.0%	96,924	12/31/2023
2023 Q3	11/13/2023	635	0.0%	96,924	9/30/2023
2023 Q2	8/11/2023	831	0.0%	96,924	6/30/2023
2023 Q1	5/15/2023	831	0.0%	96,924	3/31/2023
2022 Q3	11/14/2022	993	0.0%	96,244	9/30/2022
2022 Q2	8/12/2022	963	0.0%	96,244	6/30/2022
2022 Q1	5/16/2022	793	0.0%	64,385	3/31/2022
2021 Q4	2/14/2022	1,116	0.0%	64,385	12/31/2021
2021 Q3	11/15/2021	1,234	0.0%	68,751	9/30/2021
2021 Q2	8/16/2021	1,559	0.0%	68,184	6/30/2021